Associate Professor Mateusz Tajstra

Back

Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

Member of:

European Association of Percutaneous Cardiovascular Interventions

Presentations Articles

Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Event: ESC Congress 2025

Topic: Device Therapy

Session: Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Access

Safety of stereotactic body radiation therapy in the presence of leadless Aveir pacemaker in the in vitro model

Event: ESC Congress 2025

Topic: Device Complications and Lead Extraction

Session: Leadless pacemakers: a paradigm shift in device therapy

Access

Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies

Event: Heart Failure 2025

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies

Access

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Event: EHRA 2024

Topic: Radiotherapy

Session: Ventricular tachycardia 4

Access

Remote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure and implanted cardioverter-defibrillator or cardiac resynchronization therapy.

Event: EHRA 2019

Topic: Home and Remote Patient Monitoring

Session: Late-breaking trials 2

Access

Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.

Event: ESC Congress 2018

Topic: Outcome

Session: Outcome of coronary stenting up to 10 years

Access

Comparison of long-term mortality of hybrid coronary revascularization vs. coronary artery bypass grafting. Three-years mortality of Hybrid Revascularization for Multivessel Coronary Artery Disease (H

Event: ESC Congress 2016

Topic: Minimally invasive and robotic surgery

Session: PCI and more

Access

Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization device and defibrillator (CRT-D).

Event: ESC Congress 2016

Topic: Automatic implantable cardioverter / defibrillator

Session: Prevention sudden cardiac death and ICD therapy

Access

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Associate Professor Mateusz Tajstra Follow

Contributor content

Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Safety of stereotactic body radiation therapy in the presence of leadless Aveir pacemaker in the in vitro model

Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Remote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure and implanted cardioverter-defibrillator or cardiac resynchronization therapy.

Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.

Comparison of long-term mortality of hybrid coronary revascularization vs. coronary artery bypass grafting. Three-years mortality of Hybrid Revascularization for Multivessel Coronary Artery Disease (H

Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization device and defibrillator (CRT-D).

ESC 365 is supported by

Associate Professor Mateusz Tajstra